Inclusion Criteria:  Men and women, 18-75 years of age, with a history of chronic bilateral neuropathic foot pain (pain, numbness, tingling) secondary to T2DM for the past three months or greater. Gracely Pain Scale (GPS) rated pain severity at "moderate" or above, documented in 1-week prospective self report symptom diary (SD)(a). Primary care provider (PCP) verification of T2DM diagnosis, report of neuropathic foot pain. Successfully complete a mini-mental status exam (obtaining a score of 24 or above). Must understand and agree to complete daily symptom diaries for the duration of the study. If on pharmacologic treatment(s) must have 21 days of stable regimen (same drugs, dose & frequency) prior to enrollment.  Exclusion Criteria:  Any acute condition requiring medical care (severe heart disease, uncontrolled hypertension, lung disease, renal failure, foot lesions, sores, ingrown nails, infection etc.). Use topically applied medications to the lower extremities / feet. Allergic to smoke Alcohol and/or substance dependence. Receiving injectable corticosteroids. Receiving other complementary therapies such as herbs, massage, acupuncture etc. for foot pain. Pregnant women. Relocation or other plans that interfere with attending all of the planned study session and/or recording SD information.